HighCape is committed to a focused and specialized portfolio, which allows us to work closely with the management teams at each company to maximize their potential.
stage of growth for targeted investments
Utilizing discoveries and intellectual property licensed from Yale University, Athena has developed cutting edge approaches to probe for, identify, and characterize altered states of nicotinamide adenine dinucleotide (NAD) metabolism and flux.
The Company is focused on exploiting these unique metabolic defects with the goal of developing transformative therapeutics to treat various forms of cancer.
Athena is based in New Haven, CT
Aziyo is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices.
Utilizing proprietary tissue processing platforms, the Company has developed a portfolio of advanced regenerative medical products that are designed to be very similar to natural biological material.
The company completed an Initial Public Offering (IPO) in October 2020 and is based in Silver Springs, MD
HighCape Capital Acquisition Corp.(NASDAQ: CAPAU) is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination.
Our strategy is to identify, acquire and, after our initial business combination, build, a Life Sciences or Life Sciences related business.
The SPAC completed an Initial Public Offering (IPO) in October 2020 and is based in New York, NY
Connected medical devices
Wellinks (formerly Convexity Scientific) empowers people in their pursuit to breathe freely by developing connected medical devices and technologies to improve respiratory wellness. The first commercial product, Flyp [FDA-cleared in 2017], is a connected, pocket-portable nebulizer designed to simplify the management of chronic respiratory conditions such as asthma and COPD. The company emphasizes direct relationships with their users and is a leader in digital engagement of the empowered healthcare consumer.
The Company was founded in 2014 and is based in New Haven, CT.
Acquired by Baxter International
Non-invasive hemodynamic monitoring
Cheetah Medical was founded in 2001 with the mission of helping clinicians better manage their patient’s fluid status.
Since then, Cheetah Medical has become a leader in non-invasive Cardiac Output and Hemodynamic monitoring with its proprietary CE-marked and FDA-cleared CHEETAH NICOM™ system.
Cheetah Medical is based in Newton, Massachusetts, with offices in Tel-Aviv, Israel and Portland, Oregon.
Soft tissue surgical reconstruction devices
TELA Bio (NASDAQ: TELA) offers unique options for soft tissue repair. The Company’s innovative portfolio of soft tissue solutions combines layers of naturally-sourced tissue with interwoven polymer to enable tissue remodeling, optimize strength and minimize foreign body response. The Company’s lead product, OviTex, a Reinforced Tissue Matrix, was designed in collaboration with surgeons and healthcare providers to address the unmet clinical and financial needs in hernia repair and abdominal wall reconstruction.
The Company completed an Initial Public Offering (IPO) in November of 2019 and is based in Malvern, Pennsylvania.
Acquired December 2019
Post-surgical wound closure devices
ZipLine Medical is an innovator in cost-effective, non-invasive surgical skin closure devices that deliver high patient satisfaction and surgeon efficiency.
Zip Surgical Skin Closure devices have been used in more than 100,000 cases and in over 30 countries worldwide.
ZipLine Medical was founded by Amir Belson, M.D. and is headquartered in Campbell, CA.
Could HighCape be the right partner for your growing business?
Contact us for more information.
452 5th Ave, 21st Floor
New York, NY 10018